Ansell Limited

ANN

AU000000ANN9

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. Other stock markets 02:10:55 2024-04-23 am EDT			5-day change	1st Jan Change
25.75 ^AUD	+2.02%		+2.71%	+2.26%

Apr. 15	Ansell Launches AU$65 Million Share Purchase Plan	MT
Apr. 10	JPMorgan Upgrades Ansell to Overweight from Neutral, Price Target is AU$29.20	MT

Ansell Limited Revises Financial Guidance for the Fiscal Year 2021

February 15, 2021 at 03:31 pm EST

Ansell Limited revised financial guidance for the fiscal year 2021. The company revised EPS guidance for fiscal year 2021 to be in the range of 160 cents to 170 cents.

Latest news about Ansell Limited

Ansell Launches AU$65 Million Share Purchase Plan	Apr. 14	MT
JPMorgan Upgrades Ansell to Overweight from Neutral, Price Target is AU$29.20	Apr. 09	MT
Consumer Stocks Climb -- Consumer Roundup	Apr. 09	DJ
Australian shares advance as miners shine; US inflation data in focus	Apr. 08	RE
Ansell Raises AU$400 Million via Institutional Placement	Apr. 08	MT
Macquarie Upgrades Ansell to Outperform from Neutral, Price Target is AU$28.15	Apr. 08	MT
Sector Update: Consumer Stocks Steady Pre-Bell Monday	Apr. 08	MT
Sector Update: Consumer	Apr. 08	MT
Kimberly-Clark: personal protection sold to Ansell	Apr. 08	CF
Kimberly-Clark Selling Personal Protective Equipment Business to Ansell for $640 Million	Apr. 08	MT
News Highlights : Top Company News of the Day - Monday at 5 AM ET	Apr. 08	DJ
News Highlights : Top Company News of the Day - Monday at 3 AM ET	Apr. 08	DJ
News Highlights : Top Company News of the Day - Monday at 1 AM ET	Apr. 08	DJ
News Highlights : Top Company News of the Day - Sunday at 11 PM ET	Apr. 07	DJ
News Highlights : Top Company News of the Day - Sunday at 9 PM ET	Apr. 07	DJ
Transcript : Ansell Limited - Special Call	Apr. 07
Ansell Enters Binding Agreement to Acquire Kimberly-Clark PPE Business for $640 Million in Cash	Apr. 07	MT
Ansell Limited entered into a binding agreement to acquire Personal Protective Equipment business of Kimberly-Clark Corporation for $640 million.	Apr. 07	CI
Morgan Stanley Adjusts Ansell’s Price Target to AU$24.14 From AU$25.38, Keeps at Equalweight	Mar. 05	MT
Ansell Shares Fall 4%; H1 FY24 Revenue Declines 6%, EPS Falls	Feb. 19	MT
Transcript : Ansell Limited, H1 2024 Earnings Call, Feb 19, 2024	Feb. 19
Ansell Posts 6% Decline in H1 FY24 Revenue, EPS Falls	Feb. 19	MT
Ansell Reports H1 FY24 Revenue Down 6% to $784.9 Million; EPS of $0.154	Feb. 19	MT
Ansell Limited Declares Dividend for the Six Months Ended December 31, 2023, Payable on March 14, 2024	Feb. 19	CI
Ansell Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 19	CI

Ansell Limited is an Australia-based provider of hand and body protection solutions and an integrated manufacturer, innovator and marketer of products. The Company is principally involved in the development, manufacturing and sourcing, distribution and sale of hand and body protection solutions in the industrial and healthcare markets. It provides protection solutions to approximately 25 specific industries and protects approximately 10 million workers each day. The Company operates through two segments: Industrial Global Business Unit (GBU) and Healthcare Global Business Unit (GBU). Healthcare GBU segment is engaged in surgical and examination gloves, healthcare safety devices and active infection prevention products for healthcare professionals and patients and single-use industrial application gloves. Industrial GBU segment is engaged in multi-use hand and body protection solutions for industrial work environments and specialty applications.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-19 - Q4 2024 Earnings Release

Related indices

S&P/ASX 200

More about the company

Income Statement Evolution

More financial data

Ratings for Ansell Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

16.69 USD

Average target price

17.81 USD

Spread / Average Target

+6.71%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ANSELL LIMITED	+2.26%	2.3B
ABBOTT LABORATORIES	-1.98%	186B
MEDTRONIC PLC	-1.46%	107B
BECTON, DICKINSON AND COMPANY	-3.57%	67.57B
DEXCOM, INC.	+8.56%	50.7B
CENCORA, INC.	+15.58%	47.2B
HOYA CORPORATION	-0.45%	39.72B
WEST PHARMACEUTICAL SERVICES, INC.	+11.04%	27.48B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.46%	25.65B
TERUMO CORPORATION	+13.37%	24.97B

Other Medical Equipment, Supplies & Distribution

Ansell Limited

Equities

ANN

AU000000ANN9

Medical Equipment, Supplies & Distribution

Ansell Limited Revises Financial Guidance for the Fiscal Year 2021

Latest news about Ansell Limited

Chart Ansell Limited

Company Profile

Income Statement Evolution

Ratings for Ansell Limited

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution